111 results
DEFA14A
EX-99.1
ISEE
IVERIC bio Inc
29 Jun 23
Additional proxy soliciting materials
4:57pm
://investors.ivericbio.com/financial-information/sec-filings or by contacting the Company’s investor relations department at the following:
IVERIC bio
DEFA14A
ISEE
IVERIC bio Inc
29 Jun 23
Additional proxy soliciting materials
4:57pm
/financial-information/sec-filings or by contacting the Company’s investor relations department at the following:
IVERIC bio, Inc.
Kathy Galante
DEFM14A
ISEE
IVERIC bio Inc
5 Jun 23
Proxy related to merger
8:54am
schedules and financial statements attached thereto), (C) all material correspondence to or from the IRS, the United States Department of Labor or any … opinions issued by the IRS or the United States Department of Labor, and (E) the most recent summary plan descriptions and any material modifications thereto
DEFA14A
EX-99.1
ISEE
IVERIC bio Inc
1 Jun 23
Additional proxy soliciting materials
4:42pm
the Company’s investor relations department at the following:
IVERIC bio, Inc.
Kathy Galante
Senior Vice President, Investor Relations
kathy.galante
DEFA14A
ISEE
IVERIC bio Inc
1 Jun 23
Additional proxy soliciting materials
4:42pm
/financial-information/sec-filings or by contacting the Company’s investor relations department at the following:
IVERIC bio, Inc.
Kathy Galante
Senior
DEFA14A
EX-99.1
45e8oto rqojmd9
24 May 23
Additional proxy soliciting materials
5:25pm
DEFA14A
hgrnhw3st7vr 1y
24 May 23
Additional proxy soliciting materials
5:25pm
PREM14A
8itv xh0gos
23 May 23
Preliminary proxy related to merger
6:49am
DEFA14A
aectl4
19 May 23
Additional proxy soliciting materials
5:08pm
DEFA14A
fep05hd4ci s3
5 May 23
Additional proxy soliciting materials
4:47pm
DEFA14A
ezw5f1da
3 May 23
Additional proxy soliciting materials
4:36pm
DEFA14A
wgbzbi5
1 May 23
Additional proxy soliciting materials
4:11pm
DEFA14A
cowz4hqez 4r4b7pvtc
1 May 23
Additional proxy soliciting materials
7:05am
DEFA14A
EX-2.1
jrqmbeha pv8hh
1 May 23
Additional proxy soliciting materials
7:05am
8-K
6vfybe34u75ct1wvkmxl
1 May 23
Astellas Enters into Definitive Agreement
7:02am
8-K
EX-2.1
or5wwkdwcvbx85fo4xpb
1 May 23
Astellas Enters into Definitive Agreement
7:02am
8-K
EX-1.1
3mfsufo
5 Dec 22
Iveric Bio Announces Pricing of $300 Million Public Offering of Common Stock
7:45am